Precigen (NASDAQ:PGEN – Free Report) and NexImmune (NASDAQ:NEXI – Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation. Insider and Institutional Ownership 61.8% of Precigen shares are held by […]